In the study (P46.06 – “Cell-Free DNA (cfDNA) Methylation Assay Allows for Early Detection and Identification of Lung Cancer” ), plasma samples of 37 lung cancer patients and 71 asymptomatic ...

The algorithm enables earlier detection of lung cancer using routine general practice data. The study showed discrimination, calibration, sensitivity, and specificity under various cut-off points ...

As a founding member of the Lung Ambition Alliance, AstraZeneca is increasing screening rates and diagnostic testing, with partnerships such as the one with Qure.ai and many others. “Lung cancer ...

Source Reference: Buma AIG, et al "Lung cancer detection by electronic nose analysis of exhaled breath: A multicenter prospective external validation study" Ann Oncol 2025; DOI: 10.1016/j.annonc ...

About Viz.ai Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,700 hospitals and health systems in the U.S. and Europe.

Using this algorithm, they were able to correctly classify more than 85% of the samples as coming from lung cancer patients or those with chronic pulmonary diseases.

THE Health Ministry is open to exploring the use of artificial intelligence (AI) for disease detection, especially cancer, in public hospitals, says Datuk Seri Dr Dzulkefly Ahmad.

THE Health Ministry is open to exploring the use of artificial intelligence (AI) for disease detection, especially cancer, in public hospitals, says Datuk Seri Dr Dzulkefly Ahmad. Read full story ...